Emerald Advisers »

Celldex Therapeutics shares owned by Emerald Advisers

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $16M 456k 33.99
2024-06-30 $7.3M 198k 37.01
2024-03-31 $8.9M 212k 41.97